Get more insight from the NOBLE Registry Website
Revealing the website of the NOBLE Registry : get more [...]
Q&A: How a new imaging tool helps to better stage prostate cancer
Q&A by Doctor Jeremie Calais on how PSMA PET imaging [...]
Scandium radionuclides for theranostic applications
Learn more about the upcoming new radionuclide family of Scandium: [...]
Patient Management with Lu-177–PSMA-617 in the Clinic
Patient Management and Operationalizing Lutetium-177–PSMA-617 for Metastatic Castration Resistant Prostate [...]
Health Policy Partnership Framework
The Oncidium foundation is endorsing the Health Policy Partnership Framework, [...]
PSMA Theranostics: Current Landscape and Future Outlook
Cancers 2021, 13(16), 4023; https://doi.org/10.3390/cancers13164023, August 10, 2021, by Hanbo [...]
July 2021 – The Rising Role of Radiotheranostics
Recent Research and Developments have brought forward the pivotal [...]
Lu-177-PSMA-617A Added to Standard Therapy
VISION Trail Results Indicate Benefit of 177Lu-PSMA-617A Added to Standard [...]
Theranostic Approach in Breast Cancer
Theranostic Approach in Breast Cancer: A Treasured Tailor for Future [...]
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
With some radiopharmaceuticals now used in clinical practice, somatostatin analogs [...]